Recorded fact · drug.label_indication
drug.label_indication for dapagliflozin|type-2-diabetes
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact f9c05299 resolves to.
The record
| Fact id | f9c052998c934c66a0db5f1f |
|---|---|
| Entity | drug: dapagliflozin|type-2-diabetes |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260710 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 150d4cb575bac6e635560b94d52a6497e24915044a41466fc49d385a5f9c6364.
The value
{
"ingredient": "DAPAGLIFLOZIN",
"conditionId": "type-2-diabetes",
"conditionName": "Type 2 diabetes",
"matchedAlias": "type 2 diabetes",
"context": "indication",
"brand": "FARXIGA",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "01f90c94-71cb-4a1f-81ff-8004b850529b",
"labelEffectiveTime": "20260710",
"labelsRead": 21,
"labelsNaming": 21,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 53a68f13d7e7b4471a29c1bc58de983160b6b892c8fba6dcf56f55be862b8234.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.